Alyeska Investment Group’s Precision BioSciences DTIL Stock Holding History

Alyeska Investment Group’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$764K	Sell	138,825 -659,175	-83%	-$3.04M	﹤0.01%	581
2025 Q4	$3.32M	Buy	+798,000	New	+$4.53M	0.01%	493
2025 Q1	–	Sell	-100,000	Closed	-$381K	–	545
2024 Q4	$381K	Sell	100,000 -76,382	-43%	-$558K	﹤0.01%	525
2024 Q3	$1.58M	Hold	176,382	–	–	0.01%	435
2024 Q2	$1.72M	Sell	176,382 -73,618	-29%	-$867K	0.01%	424
2024 Q1	$3.39M	Buy	+250,000	New	+$3.06M	0.02%	354
2019 Q3	–	Sell	-3,890	Closed	-$1.55M	–	431
2019 Q2	$1.55M	Sell	3,890 -1,110	-22%	-$447K	0.02%	343
2019 Q1	$2.69M	Buy	+5,000	New	+$2.65M	0.04%	265

Other funds holding DTIL

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

EAM

Empery Asset Management New York $83M AUM

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Alyeska Investment Group's DTIL Position: Q1 2026 in Review

Alyeska Investment Group reduced its Precision BioSciences (DTIL) stake by 83% in Q1 2026, selling an estimated $3.04M and leaving 138,825 shares worth $764K. The position accounts for ﹤0.01% of the portfolio, ranked #581.

Alyeska Investment Group first reported a position in DTIL in Q1 2019 and has held it in 8 quarters since. The position peaked at $3.39M in Q1 2024. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

Alyeska Investment Group held 138,825 shares of Precision BioSciences worth $764K as of Q1 2026.
Alyeska Investment Group sold 659,175 Precision BioSciences shares in Q1 2026, an estimated $3.04M.
Precision BioSciences made up ﹤0.01% of Alyeska Investment Group's portfolio in Q1 2026, its #581 holding.
Alyeska Investment Group first reported a position in Precision BioSciences in Q1 2019 and has held it in 8 quarters since.
Alyeska Investment Group's Precision BioSciences position peaked at $3.39M in Q1 2024.
78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Alyeska Investment Group's 13F filing for Q1 2026, filed 15 May 2026.